|
Table of Contents
August 2007 (Vol. 6, No. 8) Evidence-Based ReviewsNeurocognitive impairment: Feigned, exaggerated, or real?
David J. Williamson, PhD Sedation with antipsychotics: Manage, don't accept adverse ‘calming’ effect
Del D. Miller, PharmD, MD Which to treat first: Comorbid anxiety or alcohol disorder?
Matt G. Kushner, PhD; Brenda Frye, PhD; Christopher Donahue, PhD; Sarah W. Book, MD; Carrie L. Randall, PhD Can you interpret confidence intervals? It’s not that difficult
Leslie Citrome, MD, MPH Neuroleptic malignant syndrome: Don’t let your guard down yet
Fahd A. Zarrouf, MD; Veena Bhanot, MD From The EditorSponsored CME: Do drug companies influence the content?
Henry A. Nasrallah, MD Cases That Test Your SkillsA life of drugs and ‘downtime’
Emjay M. Tan, MD; Rodney I. Eiger, MD; Jeffrey D. Roth, MD Comments & ControversiesFinancial disclosures: Readers’ right to know Cards promote depression awareness on campuses Gender misconceptions What causes PTSD? Malpractice RxHow to monitor medication side effects
Jon E. Grant, JD, MD, MPH Pearls‘DARE’ to spot borderline personality disorder
Lorraine S. Roth, MD
Subscribe to Current Psychiatry
e-alert
|
